Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018
Open accessAbstract
PROBLEM/CONDITION: Autism spectrum disorder (ASD). PERIOD COVERED: 2018. DESCRIPTION OF SYSTEM: The Autism and Developmental Disabilities Monitoring Network is an active surveillance program that estimates ASD prevalence and monitors timing of ASD identification among children aged 4 and 8 years. This report focuses on children aged 4 years in 2018, who were born in 2014 and had a parent or guardian who lived in the surveillance area in one of 11 sites (Arizona, Arkansas, California, Georgia, Maryland, Minnesota, Missouri, New Jersey, Tennessee, Utah, and Wisconsin) at any time during 2018. Children were classified as having ASD if they ever received 1) an ASD diagnostic statement (diagnosis) in an evaluation, 2) a special education classification of ASD (eligibility), or 3) an ASD International Classification of Diseases (ICD) code. Suspected ASD also was tracked among children aged 4 years. Children who did not meet the case definition for ASD were classified as having suspected ASD if their records contained a qualified professional's statement indicating a suspicion of ASD. RESULTS: For 2018, the overall ASD prevalence was 17.0 per 1,000 (one in 59) children aged 4 years. Prevalence varied from 9.1 per 1,000 in Utah to 41.6 per 1,000 in California. At every site, prevalence was higher among boys than girls, with an overall male-to-female prevalence ratio of 3.4. Prevalence of ASD among children aged 4 years was lower among non-Hispanic White (White) children (12.9 per 1,000) than among non-Hispanic Black (Black) children (16.6 per 1,000), Hispanic children (21.1 per 1,000), and Asian/Pacific Islander (A/PI) children (22.7 per 1,000). Among children aged 4 years with ASD and information on intellectual ability, 52% met the surveillance case definition of co-occurring intellectual disability (intelligence quotient ≤70 or an examiner's statement of intellectual disability documented in an evaluation). Of children aged 4 years with ASD, 72% had a first evaluation at age ≤36 months. Stratified by census-tract-level median household income (MHI) tertile, a lower percentage of children with ASD and intellectual disability was evaluated by age 36 months in the low MHI tertile (72%) than in the high MHI tertile (84%). Cumulative incidence of ASD diagnosis or eligibility received by age 48 months was 1.5 times as high among children aged 4 years (13.6 per 1,000 children born in 2014) as among those aged 8 years (8.9 per 1,000 children born in 2010). Across MHI tertiles, higher cumulative incidence of ASD diagnosis or eligibility received by age 48 months was associated with lower MHI. Suspected ASD prevalence was 2.6 per 1,000 children aged 4 years, meaning for every six children with ASD, one child had suspected ASD. The combined prevalence of ASD and suspected ASD (19.7 per 1,000 children aged 4 years) was lower than ASD prevalence among children aged 8 years (23.0 per 1,000 children aged 8 years). INTERPRETATION: Groups with historically lower prevalence of ASD (non-White and lower MHI) had higher prevalence and cumulative incidence of ASD among children aged 4 years in 2018, suggesting progress in identification among these groups. However, a lower percentage of children with ASD and intellectual disability in the low MHI tertile were evaluated by age 36 months than in the high MHI group, indicating disparity in timely evaluation. Children aged 4 years had a higher cumulative incidence of diagnosis or eligibility by age 48 months compared with children aged 8 years, indicating improvement in early identification of ASD. The overall prevalence for children aged 4 years was less than children aged 8 years, even when prevalence of children suspected of having ASD by age 4 years is included. This finding suggests that many children identified after age 4 years do not have suspected ASD documented by age 48 months. PUBLIC HEALTH ACTION: Children born in 2014 were more likely to be identified with ASD by age 48 months than children born in 2010, indicating increased early identification. However, ASD identification among children aged 4 years varied by site, suggesting opportunities to examine developmental screening and diagnostic practices that promote earlier identification. Children aged 4 years also were more likely to have co-occurring intellectual disability than children aged 8 years, suggesting that improvement in the early identification and evaluation of developmental concerns outside of cognitive impairments is still needed. Improving early identification of ASD could lead to earlier receipt of evidence-based interventions and potentially improve developmental outcomes.
AI snapshot
Written from the paper’s full text.
TL;DR
For 2018 ADDM Network surveillance, ASD prevalence among children aged 4 years across 11 sites was 17.0 per 1,000 (1 in 59), ranging from 9.1 per 1,000 in Utah to 41.6 per 1,000 in California. Early identification improved compared with children born in 2010, but timely evaluation disparities persisted for children with ASD and intellectual disability in the low median household income tertile.
Key findings
- Overall ASD prevalence was 17.0 per 1,000 children aged 4 years; male-to-female prevalence ratio was 3.4 (25.9 vs. 7.7 per 1,000). By race/ethnicity, prevalence was 12.9 per 1,000 among White children, 16.6 among Black children, 21.1 among Hispanic children, 22.7 among Asian/Pacific Islander children, and 11.5 among American Indian/Alaska Native children.
- Among children with ASD and available intellectual ability information, 51.6% had co-occurring intellectual disability; 72% had their earliest recorded evaluation by age 36 months. Among children with ASD and intellectual disability, 72% in the low MHI tertile were evaluated by age 36 months versus 84% in the high MHI tertile.
- Cumulative incidence of ASD diagnosis or eligibility by age 48 months was 13.6 per 1,000 for children born in 2014 versus 8.9 per 1,000 for children born in 2010, a 1.5 times higher incidence in the younger cohort. Suspected ASD prevalence was 2.6 per 1,000, and combined ASD plus suspected ASD prevalence was 19.7 per 1,000, still lower than ASD prevalence among children aged 8 years (23.0 per 1,000).
- Cumulative incidence by age 48 months was 13.8, 12.8, and 11.7 per 1,000 among low, middle, and high MHI tertiles, respectively, indicating higher ASD identification with lower MHI.
Methods
- Active population-based surveillance in 11 ADDM Network sites (Arizona, Arkansas, California, Georgia, Maryland, Minnesota, Missouri, New Jersey, Tennessee, Utah, and Wisconsin) among children aged 4 years in 2018, born in 2014, with a parent or guardian living in the surveillance area at least one day during 2018; total denominator was 220,394 and 3,754 children met the ASD case definition.
- Children met the ASD case definition if they ever received an ASD diagnostic statement, special education classification of ASD, or ASD ICD-9 code 299.00–299.99 or ICD-10 F84 code; suspected ASD was classified when records contained a qualified professional’s statement indicating suspicion of ASD without meeting the ASD case definition. Records were linked to health, education, birth certificate, and census-tract median household income data.
- Prevalence was calculated per 1,000 with Wilson 95% CIs; prevalence ratios compared sex and race/ethnicity groups; cumulative incidence by month of age compared children aged 4 years with children aged 8 years; risk ratios and Cochran-Armitage tests assessed differences and trends across MHI tertiles; analyses used R version 4.0.3.
Limitations
- Stated in the paper: surveillance area populations are subsets of state populations and not necessarily generalizable to entire states or the United States; sample size, demographics, and practices/policies vary among sites; differences in sites or study areas complicate comparisons over time; data completeness varied across sites; and the surveillance case definition of intellectual disability is not the same as a clinical diagnosis, with IQ measurements potentially unstable and younger children possibly not receiving an intellectual disability diagnosis.
- Evident from the text: the 2018 ASD case definition no longer required clinician review of records, which could affect prevalence estimates and comparisons, including possibly contributing to higher prevalence among Black and Hispanic children.
- Evident from the text: the ADDM Network collected data about children evaluated for and identified with ASD but not about screening and referrals, limiting interpretation of barriers to timely and equitable identification.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 41 cited sources checked · 0 supported · 0 flagged
- Findingown data
The prevalence of suspected ASD ranged from 0.4 per 1,000 in California to 4.9 per 1,000 in Arizona.
“The overall prevalence of children without an ASD diagnosis, eligibility, or ICD code but who were suspected by a qualified professional of having ASD was 2.6 per 1,000 children aged 4 years (range: 0.4 per 1,000 in California to 4.9 per 1,000 in Arizona) (Table 7) (Supplementary Figure 4, https://stacks.cdc.gov/view/cdc/111177).”
Quote in the paperNot a substantial claim - Findingown data
An overall association of higher ASD identification by age 48 months with lower MHI was observed.
“An overall association of higher ASD identification by age 48 months with lower MHI was observed.”
- Also stated in: § Conclusion · plain
“ASD prevalence among children aged 4 years was higher among Black, Hispanic, and A/PI children than among White children, and higher cumulative incidence of ASD diagnosis or eligibility by age 48 months was associated with lower census-tract–level MHI.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · plain
- Findingown data
The percentage of children with co-occurring intellectual disability was not different between boys (51%) and girls (53%) with ASD.
“The percentage of children with co-occurring intellectual disability was not different between boys (51%) and girls (53%) with ASD (Table 4).”
Quote in the paperNot a substantial claim - Findingown data
Of children aged 4 years with ASD, 72% had a first evaluation at age ≤36 months.
“Of children aged 4 years with ASD, 72% had a first evaluation at age ≤36 months.”
Quote in the paperSubstantial claim - Findingown data
Trends were not observed among the other five sites.
“Trends were not observed among the other five sites.”
Quote in the paperNot a substantial claim
- Findingown data
ASD prevalence among children aged 4 years was lower among White children (12.9 per 1,000) than among Asian/Pacific Islander children (22.7 per 1,000).
“Prevalence of ASD among children aged 4 years was lower among non-Hispanic White (White) children (12.9 per 1,000) than among non-Hispanic Black (Black) children (16.6 per 1,000), Hispanic children (21.1 per 1,000), and Asian/Pacific Islander (A/PI) children (22.7 per 1,000).”
- Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
“Overall, prevalence was lower among White children than among Black children (prevalence ratio: 0.8), Hispanic children (prevalence ratio: 0.6), and A/PI children (prevalence ratio: 0.6) (Table 3).”
Quote in the paperNot a substantial claim - Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
- Findingown data
The percentage of children with earliest recorded evaluation by age 36 months was similar for children classified as having intellectual disability (78%) or not (80%).
“The percentage of children with earliest recorded evaluation by age 36 months was similar for children classified as having intellectual disability (78%) or not (80%) but was lower among children with unknown intellectual disability case status (63%).”
Quote in the paperNot a substantial claim - Findingown data
Cumulative incidence by age 48 months was higher with higher MHI in one site (Missouri).
“Cumulative incidence by age 48 months was higher with higher MHI in one site (Missouri).”
Quote in the paperNot a substantial claim - Findingown data
Across median household income tertiles, higher cumulative incidence of ASD diagnosis or eligibility received by age 48 months was associated with lower MHI.
“Across MHI tertiles, higher cumulative incidence of ASD diagnosis or eligibility received by age 48 months was associated with lower MHI.”
Quote in the paperSubstantial claim - Findingown data
Across sites, six children met the ASD case definition for every child meeting the suspected case definition.
“Across sites, six children met the ASD case definition for every child meeting the suspected case definition.”
Quote in the paperNot a substantial claim - Findingown data
Among children with intellectual disability, a lower percentage was evaluated by age 36 months among the low SES group (72%) than among the high SES group (84%).
“However, among children with intellectual disability, a lower percentage was evaluated by age 36 months among the low SES group (72%) than among the high SES group (84%) (Supplementary Table 4, https://stacks.cdc.gov/view/cdc/111177).”
- Also stated in: § Conclusion · hedged
“However, a lower percentage of children with ASD and intellectual disability in the low MHI tertile were evaluated by age 36 months than in the high MHI group, suggesting there could still be disparities in receiving timely evaluation.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · hedged
- Findingown data
ASD prevalence among children aged 4 years was lower among White children (12.9 per 1,000) than among Hispanic children (21.1 per 1,000).
“Prevalence of ASD among children aged 4 years was lower among non-Hispanic White (White) children (12.9 per 1,000) than among non-Hispanic Black (Black) children (16.6 per 1,000), Hispanic children (21.1 per 1,000), and Asian/Pacific Islander (A/PI) children (22.7 per 1,000).”
- Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
“Overall, prevalence was lower among White children than among Black children (prevalence ratio: 0.8), Hispanic children (prevalence ratio: 0.6), and A/PI children (prevalence ratio: 0.6) (Table 3).”
Quote in the paperNot a substantial claim - Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
- Findingown data
In Arizona, ASD prevalence among White children aged 4 years was 1.6 times as high as among Hispanic children.
“The two exceptions to the overall patterns were in Arizona, where prevalence among White children was 1.6 times as high as among Hispanic children, and in Georgia, where prevalence among Black children was 1.7 times as high as among Hispanic children.”
Quote in the paperNot a substantial claim - Findingown data
In Georgia, ASD prevalence among Black children aged 4 years was 1.7 times as high as among Hispanic children.
“The two exceptions to the overall patterns were in Arizona, where prevalence among White children was 1.6 times as high as among Hispanic children, and in Georgia, where prevalence among Black children was 1.7 times as high as among Hispanic children.”
Quote in the paperNot a substantial claim - Findingown data
Children aged 4 years were more likely to have co-occurring intellectual disability than children aged 8 years.
“Children aged 4 years also were more likely to have co-occurring intellectual disability than children aged 8 years, suggesting that improvement in the early identification and evaluation of developmental concerns outside of cognitive impairments is still needed.”
Quote in the paperSubstantial claim - Findingown data
The pattern of higher cumulative incidence in children born in 2014 was evident for nine of 11 sites, with range 1.2 times as high in New Jersey to 2.1 times as high in Wisconsin.
“The pattern was evident for nine of 11 sites (range: 1.2 times as high in New Jersey to 2.1 times as high in Wisconsin); however, the cumulative incidence curve for children born in 2014 overlapped with the curve for children born in 2010 in Arkansas and Utah (Figure 2).”
Quote in the paperNot a substantial claim - Findingown data
Among children aged 4 years with ASD and available intellectual ability information, 51.6% had co-occurring intellectual disability according to the surveillance case definition.
“Among children aged 4 years with ASD and information on intellectual ability, 52% met the surveillance case definition of co-occurring intellectual disability (intelligence quotient ≤70 or an examiner’s statement of intellectual disability documented in an evaluation).”
- Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
“Among the group of children with data available, 51.6% of children with ASD had co-occurring intellectual disability according to the surveillance case definition (range: 23.1% in California to 76.3% in Maryland) (Table 4).”
Quote in the paperNot a substantial claim - Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
- Findingown data
No evidence of heterogeneity of the male-to-female ASD prevalence ratio among children aged 4 years across sites was observed.
“No evidence of heterogeneity of the male-to-female ratio among children aged 4 years across sites was observed; however, the overall male-to-female ratio for children aged 4 years was lower than the 4.2 male-to-female ratio for children aged 8 years (11).”
Quote in the paperNot a substantial claim - Findingown data
Stratified by census-tract-level median household income tertile, a lower percentage of children with ASD and intellectual disability was evaluated by age 36 months in the low MHI tertile (72%) than in the high MHI tertile (84%).
“Stratified by census-tract–level median household income (MHI) tertile, a lower percentage of children with ASD and intellectual disability was evaluated by age 36 months in the low MHI tertile (72%) than in the high MHI tertile (84%).”
Quote in the paperNot a substantial claim - Findingown data
For 2018, the overall ASD prevalence among children aged 4 years across the 11 ADDM Network sites was 17.0 per 1,000 (one in 59).
“For 2018, the overall ASD prevalence was 17.0 per 1,000 (one in 59) children aged 4 years.”
- Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
“For 2018, ASD prevalence in the 11 sites combined was 17.0 per 1,000 (1 in 59) children aged 4 years.”
Quote in the paperSubstantial claim - Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
- Findingown data
The percentage of children with earliest recorded evaluation by age 36 months was lower among children with unknown intellectual disability case status (63%) than among children with known intellectual disability status.
“The percentage of children with earliest recorded evaluation by age 36 months was similar for children classified as having intellectual disability (78%) or not (80%) but was lower among children with unknown intellectual disability case status (63%).”
Quote in the paperNot a substantial claim - Findingown data
Overall, 72% of children with ASD with an evaluation had their earliest recorded evaluation by age 36 months.
“Overall, 72% of children with ASD with an evaluation had their earliest recorded evaluation by age 36 months, with variability across sites ranging from 66% in Utah and Wisconsin to 83% in Maryland (Table 5).”
Quote in the paperSubstantial claim - Findingown data
The overall male-to-female ASD prevalence ratio among children aged 4 years was 3.4.
“At every site, prevalence was higher among boys than girls, with an overall male-to-female prevalence ratio of 3.4.”
- Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
“Among boys aged 4 years, prevalence was 25.9 per 1,000, which was 3.4 times as high as the 7.7 per 1,000 prevalence among girls aged 4 years (Table 2).”
Quote in the paperNot a substantial claim - Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
- Findingown data
Overall, 53.4% of children aged 4 years with ASD had information on intellectual ability available.
“Overall, 53.4% of children aged 4 years with ASD had information on intellectual ability available (range: 18.6% in Missouri to 77.7% in California) (Supplementary Table 3, https://stacks.cdc.gov/view/cdc/111177).”
Quote in the paperNot a substantial claim - Findingown data
Children aged 4 years (born in 2014) had a higher cumulative incidence of ASD diagnosis or eligibility by age 48 months than children aged 8 years (born in 2010).
“Compared with children aged 8 years (born in 2010), children aged 4 years (born in 2014) had a higher cumulative incidence of ASD diagnosis or eligibility by age 48 months (Figure 2).”
- Also stated in: § Conclusion · hedged
“Comparing across ADDM cohorts, cumulative incidence of ASD identification by age 48 months was higher among children born in 2014 compared with those born in 2010, which further suggests improvements in early identification have occurred.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · hedged
- Findingown data
Among children aged 4 years, ASD prevalence was 25.9 per 1,000 among boys.
“Among boys aged 4 years, prevalence was 25.9 per 1,000, which was 3.4 times as high as the 7.7 per 1,000 prevalence among girls aged 4 years (Table 2).”
Quote in the paperNot a substantial claim - Findingown data
No trend was observed in evaluation by age 36 months by MHI tertile overall.
“No trend was observed in evaluation by age 36 months by MHI tertile overall.”
Quote in the paperNot a substantial claim - Findingown data
The combined prevalence of ASD and suspected ASD (19.7 per 1,000 children aged 4 years) was lower than ASD prevalence among children aged 8 years (23.0 per 1,000).
“The combined prevalence of ASD and suspected ASD (19.7 per 1,000 children aged 4 years) was lower than ASD prevalence among children aged 8 years (23.0 per 1,000 children aged 8 years).”
- Also stated in: § Interpretation · plain
“The overall prevalence for children aged 4 years was less than children aged 8 years, even when prevalence of children suspected of having ASD by age 4 years is included.”
Quote in the paperSubstantial claim - Also stated in: § Interpretation · plain
- Findingown data
The percentage of children with earliest recorded evaluation by age 36 months varied across sites, ranging from 66% in Utah and Wisconsin to 83% in Maryland.
“Overall, 72% of children with ASD with an evaluation had their earliest recorded evaluation by age 36 months, with variability across sites ranging from 66% in Utah and Wisconsin to 83% in Maryland (Table 5).”
Quote in the paperSubstantial claim - Findingown data
ASD prevalence among children aged 4 years varied across ADDM sites from 9.1 per 1,000 in Utah to 41.6 per 1,000 in California.
“Prevalence varied from 9.1 per 1,000 in Utah to 41.6 per 1,000 in California.”
- Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
“Estimates ranged widely across the sites, from 9.1 per 1,000 in Utah to 41.6 per 1,000 in California (Table 1).”
Quote in the paperNot a substantial claim - Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
- Findingown data
Five of 11 sites (Arizona, California, Tennessee, Utah, and Wisconsin) demonstrated the same association of higher cumulative ASD incidence with lower MHI tertile.
“Five of 11 sites (Arizona, California, Tennessee, Utah, and Wisconsin) demonstrated the same association of higher cumulative ASD incidence with lower MHI tertile (Table 6) (Supplementary Figure 3, https://stacks.cdc.gov/view/cdc/111177).”
Quote in the paperNot a substantial claim - Findingown data
ASD prevalence among children aged 4 years was lower among White children (12.9 per 1,000) than among Black children (16.6 per 1,000).
“Prevalence of ASD among children aged 4 years was lower among non-Hispanic White (White) children (12.9 per 1,000) than among non-Hispanic Black (Black) children (16.6 per 1,000), Hispanic children (21.1 per 1,000), and Asian/Pacific Islander (A/PI) children (22.7 per 1,000).”
- Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
“Overall, prevalence was lower among White children than among Black children (prevalence ratio: 0.8), Hispanic children (prevalence ratio: 0.6), and A/PI children (prevalence ratio: 0.6) (Table 3).”
Quote in the paperNot a substantial claim - Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
- Findingown data
The cumulative incidence curve for children born in 2014 overlapped with the curve for children born in 2010 in Arkansas and Utah.
“The pattern was evident for nine of 11 sites (range: 1.2 times as high in New Jersey to 2.1 times as high in Wisconsin); however, the cumulative incidence curve for children born in 2014 overlapped with the curve for children born in 2010 in Arkansas and Utah (Figure 2).”
Quote in the paperNot a substantial claim - Findingown data
Among children without intellectual disability, the percentages evaluated by age 36 months were similar across MHI tertiles.
“In contrast, the percentages of children evaluated by age 36 months were similar across MHI tertiles among children without intellectual disability (Supplementary Table 4, https://stacks.cdc.gov/view/cdc/111177).”
Quote in the paperNot a substantial claim - Findingown data
Prevalence among White children aged 4 years was lower than among Black, Hispanic, and Asian/Pacific Islander children at five of 11 sites each.
“Prevalence among White children was lower than among Black, Hispanic, and A/PI children at five of 11 sites each.”
Quote in the paperNot a substantial claim - Findingown data
The percentage of children with ASD with intellectual disability was higher among Black children (67%) than among White, Asian/Pacific Islander, and Hispanic children.
“The percentage of children with ASD with intellectual disability was similar among White, A/PI, and Hispanic children (50%, 48%, and 45%, respectively) but was higher among Black children (67%).”
Quote in the paperNot a substantial claim - Findingown data
Cumulative incidence of ASD diagnosis or eligibility by age 48 months was 13.8, 12.8, and 11.7 per 1,000 children aged 4 years among low, middle, and high MHI tertiles, respectively.
“Cumulative incidence of ASD diagnosis or eligibility by age 48 months was 13.8, 12.8, and 11.7 per 1,000 children aged 4 years among low, middle, and high MHI tertiles, respectively.”
Quote in the paperSubstantial claim - Findingown data
At every ADDM site, ASD prevalence among children aged 4 years was higher among boys than girls.
“At every site, prevalence was higher among boys than girls, with an overall male-to-female prevalence ratio of 3.4.”
- Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
“Prevalence significantly higher among males than females at all sites (prevalence ratio 95% CIs do not include 1.0).”
Quote in the paperNot a substantial claim - Also stated in: § Prevalence and Characteristics of Children Aged 4 Years with ASD · plain
- Findingown data
The percentage of children with ASD with intellectual disability was similar among White, Asian/Pacific Islander, and Hispanic children (50%, 48%, and 45%, respectively).
“The percentage of children with ASD with intellectual disability was similar among White, A/PI, and Hispanic children (50%, 48%, and 45%, respectively) but was higher among Black children (67%).”
Quote in the paperNot a substantial claim - Findingcitation
The overall male-to-female ASD prevalence ratio for children aged 4 years was lower than the 4.2 ratio for children aged 8 years.
“No evidence of heterogeneity of the male-to-female ratio among children aged 4 years across sites was observed; however, the overall male-to-female ratio for children aged 4 years was lower than the 4.2 male-to-female ratio for children aged 8 years (11).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Maenner, 2021, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018., MMWR Surveill Summ source
Not checked in the free run.
- Findingown data
The overall prevalence of children without an ASD diagnosis, eligibility, or ICD code but who were suspected by a qualified professional of having ASD was 2.6 per 1,000 children aged 4 years.
“The overall prevalence of children without an ASD diagnosis, eligibility, or ICD code but who were suspected by a qualified professional of having ASD was 2.6 per 1,000 children aged 4 years (range: 0.4 per 1,000 in California to 4.9 per 1,000 in Arizona) (Table 7) (Supplementary Figure 4, https://stacks.cdc.gov/view/cdc/111177).”
Quote in the paperNot a substantial claim - Findingown data
ASD prevalence was not different between Hispanic and Asian/Pacific Islander children aged 4 years.
“Prevalence was not different between Hispanic and A/PI children.”
Quote in the paperNot a substantial claim - Findingown data
Cumulative incidence of ASD diagnosis or eligibility received by age 48 months was 1.5 times as high among children aged 4 years (13.6 per 1,000 children born in 2014) as among children aged 8 years (8.9 per 1,000 children born in 2010).
“Cumulative incidence of ASD diagnosis or eligibility received by age 48 months was 1.5 times as high among children aged 4 years (13.6 per 1,000 children born in 2014) as among those aged 8 years (8.9 per 1,000 children born in 2010).”
Quote in the paperSubstantial claim - Findingown data
Among children aged 4 years, ASD prevalence was 7.7 per 1,000 among girls.
“Among boys aged 4 years, prevalence was 25.9 per 1,000, which was 3.4 times as high as the 7.7 per 1,000 prevalence among girls aged 4 years (Table 2).”
Quote in the paperNot a substantial claim - Findingown data
American Indian/Alaska Native children aged 4 years had ASD prevalence of 11.5 per 1,000.
“Overall, A/PI children had the highest prevalence of ASD at 22.7 per 1,000 children aged 4 years, followed by Hispanic children at 21.1 per 1,000, Black children at 16.6 per 1,000, White children at 12.9 per 1,000, and AI/AN children at 11.5 per 1,000.”
Quote in the paperNot a substantial claim - Findingown data
ASD prevalence among Black children aged 4 years was significantly lower than among Asian/Pacific Islander children (prevalence ratio 0.7).
“The prevalence among Black children, although significantly higher than among White children, also was significantly lower than among Hispanic and A/PI children (prevalence ratios: 0.8 and 0.7, respectively).”
Quote in the paperNot a substantial claim - Findingown data
ASD diagnosis or eligibility was 1.5 times as high in the group born in 2014 as in the group born in 2010.
“At age 48 months, overall cumulative incidence was 13.6 per 1,000 children born in 2014 and 8.9 per 1,000 children born in 2010, meaning ASD diagnosis or eligibility was 1.5 times as high in the group born in 2014 (Supplementary Table 5, https://stacks.cdc.gov/view/cdc/111177).”
Quote in the paperSubstantial claim - Findingown data
ASD prevalence among Black children aged 4 years was significantly lower than among Hispanic children (prevalence ratio 0.8).
“The prevalence among Black children, although significantly higher than among White children, also was significantly lower than among Hispanic and A/PI children (prevalence ratios: 0.8 and 0.7, respectively).”
Quote in the paperNot a substantial claim - Findingown data
Among children with data available, co-occurring intellectual disability was less common among children with suspected ASD (41%) than among those with ASD (52%).
“In addition, among children with data available, co-occurring intellectual disability was less common among children with suspected ASD (41%) than among those with ASD (52%).”
Quote in the paperNot a substantial claim - Findingown data
In 2018, the inverse association of higher ASD identification in the group with lower MHI was observed among children aged 4 years in the ADDM Network.
“In 2018, the inverse association of higher ASD identification in the group with lower MIH was observed among children aged 4 years in the ADDM Network, consistent with reports using recent California Department of Developmental Services data (20) and England Spring School Census data (21).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [20] Winter, 2020, The social patterning of autism diagnoses reversed in California between 1992 and 2018., Proc Natl Acad Sci U S A source
Not checked in the free run.
- cites [21] Roman-Urrestarazu, 2021, Association of race/ethnicity and social disadvantage with autism prevalence in 7 million school children in England., JAMA Pediatr source
Not checked in the free run.
- Findingcitation
California was the only site where prevalence among children aged 4 years was higher than among children aged 8 years.
“The site in California had the highest cumulative incidence of ASD by age 48 months and the fewest cases of suspected ASD and was the only site where prevalence among children aged 4 years was higher than among children aged 8 years (11).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Maenner, 2021, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018., MMWR Surveill Summ source
Not checked in the free run.
- Findingcitation
A higher proportion of Black children aged 4 years with ASD have co-occurring intellectual disability.
“Consistent with findings among children aged 8 years (11), a higher proportion of Black children aged 4 years with ASD have co-occurring intellectual disability.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Maenner, 2021, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018., MMWR Surveill Summ source
Not checked in the free run.
- Findingcitation
Children in the lower MHI group were more likely to have co-occurring intellectual disability.
“Children in the lower MHI group were more likely to have co-occurring intellectual disability, consistent with previous ADDM Network reports (19,22) and a study in France (23).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [19] Durkin, 2017, Autism spectrum disorder among US children (2002–2010): socioeconomic, racial, and ethnic disparities., Am J Public Health source
Not checked in the free run.
- cites [22] Patrick, 2021, Prevalence of intellectual disability among eight-year-old children from selected communities in the United States, 2014., Disabil Health J source
Not checked in the free run.
- cites [23] Delobel-Ayoub, 2015, Socioeconomic disparities and prevalence of autism spectrum disorders and intellectual disability., PLoS One source
Not checked in the free run.
- Findingown data
No association was observed between suspected ASD and SES.
“Although ASD was identified more frequently among children in lower SES groups, no association was observed between suspected ASD and SES.”
Quote in the paperNot a substantial claim - Findingcitation
The 2018 estimate for children aged 4 years was lower than the 23.0 per 1,000 ASD prevalence among children aged 8 years.
“The 2018 estimate for children aged 4 years was lower than the 23.0 per 1,000 ASD prevalence among children aged 8 years (11), a finding consistent with previous reports (8,13).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [11] Maenner, 2021, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018., MMWR Surveill Summ source
Not checked in the free run.
- cites [8] Shaw, 2020, Early identification of autism spectrum disorder among children aged 4 years—Early Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
- cites [13] Christensen, 2019, Prevalence and characteristics of autism spectrum disorder among children aged 4 years—Early Autism and Developmental Disabilities Monitoring Network, seven sites, United States, 2010, 2012, and 2014., MMWR Surveill Summ source
Not checked in the free run.
- Findingreasoning
The sex ratio of boys to girls was higher at age 8 years than at age 4 years.
“The sex ratio is one example of how differences in identification of children without intellectual disability can affect patterns observed at older ages, with a higher ratio of boys to girls at age 8 years than at age 4 years, consistent with previous reports (8,9).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [8] Shaw, 2020, Early identification of autism spectrum disorder among children aged 4 years—Early Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
- cites [9] Maenner, 2020, Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
- Findingown data
Incidence of ASD identification was lower among Hispanic than among White children at only one site (Arizona).
“Incidence of ASD identification was lower among Hispanic than among White children at only one site (Arizona).”
Quote in the paperNot a substantial claim - Findingcitation
The combined prevalence of ASD and suspected ASD (19.7 per 1,000 children aged 4 years) was still lower than ASD prevalence observed among children aged 8 years (23.0 per 1,000 children aged 8 years).
“The combined prevalence of ASD and suspected ASD (19.7 per 1,000 children aged 4 years) was still lower than ASD prevalence observed among children aged 8 years (23.0 per 1,000 children aged 8 years) (11).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Maenner, 2021, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018., MMWR Surveill Summ source
Not checked in the free run.
- Findingcitation
The ASD prevalence of 17.0 per 1,000 children aged 4 years for 2018 was higher than for 2016, when prevalence was 15.6 per 1,000.
“The ASD prevalence of 17.0 per 1,000 children aged 4 years for 2018 was higher than for 2016, when prevalence was 15.6 per 1,000 (8).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Shaw, 2020, Early identification of autism spectrum disorder among children aged 4 years—Early Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
- Findingown data
California had the fewest cases of suspected ASD among sites.
“The site in California had the highest cumulative incidence of ASD by age 48 months and the fewest cases of suspected ASD and was the only site where prevalence among children aged 4 years was higher than among children aged 8 years (11).”
Quote in the paperNot a substantial claim - Findingcitation
Adding the children identified with ASD to those suspected of having ASD at age 4 years is still less than the prevalence of ASD by age 8 years at all sites except California.
“Adding the children identified with ASD to those suspected of having ASD at age 4 years is still less than the prevalence of ASD by age 8 years at all sites except California (11).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Maenner, 2021, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018., MMWR Surveill Summ source
Not checked in the free run.
- Findingown data
The ratio of children with ASD to children with suspected ASD ranged from 116:1 in California to 2:1 in Arizona.
“The ratio of children with ASD to children with suspected ASD ranged from 116:1 in California to 2:1 in Arizona.”
Quote in the paperNot a substantial claim - Findingown data
California had the highest cumulative incidence of ASD by age 48 months among sites.
“The site in California had the highest cumulative incidence of ASD by age 48 months and the fewest cases of suspected ASD and was the only site where prevalence among children aged 4 years was higher than among children aged 8 years (11).”
Quote in the paperNot a substantial claim - Findingown data
In 2018, prevalence was higher among Hispanic children than among White children at five sites, including New Jersey, and overall.
“In 2018, prevalence was higher among Hispanic children than among White children at five sites, including New Jersey, and overall.”
Quote in the paperSubstantial claim - Findingown data
Children with ASD and children with suspected ASD did not differ by sex (78% male and 76% male, respectively).
“Children with ASD and children with suspected ASD did not differ by sex (78% male and 76% male, respectively).”
Quote in the paperNot a substantial claim - Findingown data
Similar proportions of children with ASD or suspected ASD were evaluated by age 36 months.
“Similar proportions of children with ASD or suspected ASD were evaluated by age 36 months.”
Quote in the paperNot a substantial claim - Findingown data
ASD prevalence among children aged 4 years was lower compared with children aged 8 years at most ADDM sites, even when prevalence of children with suspected ASD by age 4 years is included.
“ASD prevalence among children aged 4 years was lower compared with children aged 8 years at most ADDM sites, even when prevalence of children with suspected ASD by age 4 years is included.”
Quote in the paperSubstantial claim - Findingown data
ASD prevalence among children aged 4 years was higher among Black, Hispanic, and A/PI children than among White children.
“ASD prevalence among children aged 4 years was higher among Black, Hispanic, and A/PI children than among White children, and higher cumulative incidence of ASD diagnosis or eligibility by age 48 months was associated with lower census-tract–level MHI.”
Quote in the paperSubstantial claim - Interpretationown data
Among children aged 4 years in 2018, groups with historically lower ASD prevalence (non-White and lower MHI) had higher prevalence and cumulative incidence of ASD.
“Groups with historically lower prevalence of ASD (non-White and lower MHI) had higher prevalence and cumulative incidence of ASD among children aged 4 years in 2018, suggesting progress in identification among these groups.”
Quote in the paperSubstantial claim- Rests on an assumption: Non-White and lower median household income groups have historically had lower ASD prevalence.
- Interpretationown data
The finding that combined ASD and suspected ASD prevalence among children aged 4 years was lower than ASD prevalence among children aged 8 years suggests that many children identified after age 4 years do not have suspected ASD documented by age 48 months.
“This finding suggests that many children identified after age 4 years do not have suspected ASD documented by age 48 months.”
Quote in the paperSubstantial claim - Interpretationown data
The higher prevalence and cumulative incidence among non-White and lower MHI groups suggests progress in identification among these groups.
“Groups with historically lower prevalence of ASD (non-White and lower MHI) had higher prevalence and cumulative incidence of ASD among children aged 4 years in 2018, suggesting progress in identification among these groups.”
Quote in the paperSubstantial claim- Rests on an assumption: Non-White and lower median household income groups have historically had lower ASD prevalence.
- Interpretationown data
A lower percentage of children with ASD and intellectual disability in the low MHI tertile evaluated by age 36 months than in the high MHI group indicates disparity in timely evaluation.
“However, a lower percentage of children with ASD and intellectual disability in the low MHI tertile were evaluated by age 36 months than in the high MHI group, indicating disparity in timely evaluation.”
Quote in the paperSubstantial claim - Study design and conductreasoning
With the expansion of ASD surveillance among children aged 4 years to the same surveillance areas as among children aged 8 years, surveillance year 2018 was the first year that sufficient data for A/PI and AI/AN children were available for presentation.
“With the expansion of ASD surveillance among children aged 4 years to the same surveillance areas as among children aged 8 years, surveillance year 2018 was the first year that sufficient data for A/PI and AI/AN children were available for presentation.”
Quote in the paperNot a substantial claim - Interpretationcitation
Underascertainment of Black children without intellectual disability across age groups could have a role in the disparity of higher co-occurring intellectual disability among Black children with ASD.
“Underascertainment of Black children without intellectual disability across age groups, which has been reported among Black and Hispanic children relative to White children without intellectual disability from surveillance years 2002–2016 (10), could have a role in this disparity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Shaw K. Progress and disparities in the early identification of autism spectrum disorder—ADDM Network, 2002–2016. J Am Acad Child Adolesc Psychiatry. In press.
Not checked in the free run.
- Premisecitation
Children with co-occurring intellectual disability are more likely to be identified earlier than children without intellectual disability.
“Children with co-occurring intellectual disability are more likely to be identified earlier than children without intellectual disability, as indicated by an earlier median age at identification among this group (11) as well as the consistently higher proportion of children with intellectual disability at age 4 years (8,13) than at age 8 years (9,11,17).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [11] Maenner, 2021, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018., MMWR Surveill Summ source
Not checked in the free run.
- cites [8] Shaw, 2020, Early identification of autism spectrum disorder among children aged 4 years—Early Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
- cites [13] Christensen, 2019, Prevalence and characteristics of autism spectrum disorder among children aged 4 years—Early Autism and Developmental Disabilities Monitoring Network, seven sites, United States, 2010, 2012, and 2014., MMWR Surveill Summ source
Not checked in the free run.
- cites [9] Maenner, 2020, Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
- cites [17] Baio, 2018, Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2014., MMWR Surveill Summ source
Not checked in the free run.
- Interpretationcitation
A change to the ASD case definition for 2018 that no longer required clinician review of records could also contribute to higher prevalence among Black and Hispanic children who were less likely to have detailed health information available for review and therefore less likely to meet the case definition with previous methods.
“A change to the ASD case definition for 2018 that no longer required clinician review of records (12) could also contribute to higher prevalence among Black and Hispanic children who were less likely to have detailed health information available for review and therefore less likely to meet the case definition with previous methods (18).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [12] Maenner, 2021, Comparison of two case definitions for ascertaining prevalence of autism spectrum disorder among 8-year-old children., Am J Epidemiol source
Not checked in the free run.
- cites [18] Imm, 2019, Assessment of racial and ethnic bias in autism spectrum disorder prevalence estimates from a US surveillance system., Autism source
Not checked in the free run.
- Premisecitation
In 2016, prevalence was higher among Hispanic compared with White children aged 4 years at one site (New Jersey) and overall.
“In 2016, prevalence was higher among Hispanic compared with White children aged 4 years higher at one site (New Jersey) and overall (8).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Shaw, 2020, Early identification of autism spectrum disorder among children aged 4 years—Early Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
- Interpretationown data
Findings from the ADDM Network 2018 surveillance year indicate patterns of ASD identification among children aged 4 years that are different from what has been previously reported.
“Findings from the ADDM Network 2018 surveillance year indicate patterns of ASD identification among children aged 4 years that are different from what has been previously reported.”
Quote in the paperSubstantial claim - Interpretationreasoning
Many children with ASD identified by age 8 years do not have suspected ASD documented by age 4 years.
“This suggests many children with ASD identified by age 8 years do not have suspected ASD documented by age 4 years.”
Quote in the paperSubstantial claim - Interpretationreasoning
These findings could indicate improvements in ASD identification among historically underserved populations.
“These findings could indicate improvements in ASD identification among historically underserved populations.”
Quote in the paperSubstantial claim - Interpretationown data
The higher cumulative incidence among children born in 2014 suggests improvements in early identification have occurred.
“Comparing across ADDM cohorts, cumulative incidence of ASD identification by age 48 months was higher among children born in 2014 compared with those born in 2010, which further suggests improvements in early identification have occurred.”
Quote in the paperSubstantial claim - Interpretationown data
The lower percentage of children with ASD and intellectual disability in the low MHI tertile evaluated by age 36 months suggests there could still be disparities in receiving timely evaluation.
“However, a lower percentage of children with ASD and intellectual disability in the low MHI tertile were evaluated by age 36 months than in the high MHI group, suggesting there could still be disparities in receiving timely evaluation.”
Quote in the paperSubstantial claim
- May combine two claims. 21
- Classified as probably not a substantial claim. 17
May combine two claims.
Findingown dataSuspected ASD prevalence was 2.6 per 1,000 children aged 4 years, corresponding to one child with suspected ASD for every six children with ASD.
“Suspected ASD prevalence was 2.6 per 1,000 children aged 4 years, meaning for every six children with ASD, one child had suspected ASD.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataEvaluation by age 36 months was similar by sex and by racial and ethnic groups.
“Evaluation by age 36 months was similar by sex and by racial and ethnic groups.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCo-occurring intellectual disability among children aged 4 years with ASD was associated with lower median household income; 41% in the high MHI tertile had intellectual disability compared with 60% in the low MHI tertile.
“Co-occurring intellectual disability was associated with lower MHI; 41% of those in the high MHI tertile group had intellectual disability compared with 60% of those in the low MHI tertile group.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAt age 48 months, overall cumulative incidence was 13.6 per 1,000 children born in 2014 and 8.9 per 1,000 children born in 2010.
“At age 48 months, overall cumulative incidence was 13.6 per 1,000 children born in 2014 and 8.9 per 1,000 children born in 2010, meaning ASD diagnosis or eligibility was 1.5 times as high in the group born in 2014 (Supplementary Table 5, https://stacks.cdc.gov/view/cdc/111177).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPrevalence of ASD was higher than prevalence of suspected ASD, although the magnitude varied across sites.
“Prevalence of ASD was higher than prevalence of suspected ASD, although the magnitude varied across sites.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDifferences were observed by race and ethnicity, with more White children (50%) and fewer A/PI children (5%) in the suspected ASD group than in the ASD group (43% White; 9% A/PI).
“Differences were observed by race and ethnicity, with more White children (50%) and fewer A/PI children (5%) in the suspected ASD group than in the ASD group (43% White; 9% A/PI) (Table 8).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn surveillance year 2018, ASD prevalence among Black children was higher than among White children at five of 11 sites and overall.
“In surveillance year 2018, ASD prevalence among Black children was higher than among White children at five of 11 sites and overall, the opposite of the pattern before surveillance year 2016 among children aged 8 years (9,17).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Maenner, 2020, Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
- cites [17] Baio, 2018, Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2014., MMWR Surveill Summ source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
PremisecitationEarly evaluation, diagnosis, and evidence-based interventions could enhance short-term and long-term developmental outcomes for young children with ASD.
“Early routine screening for ASD and other developmental concerns is recommended by the American Academy of Pediatrics (1) because early evaluation, diagnosis, and evidence-based interventions could enhance short-term and long-term developmental outcomes for young children with ASD (2–6).”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [2] Reichow, 2018, Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD)., Cochrane Database Syst Rev source
Not checked in the free run.
- cites [3] Rogers, 2012, Effects of a brief Early Start Denver Model (ESDM)-based parent intervention on toddlers at risk for autism spectrum disorders: a randomized controlled trial., J Am Acad Child Adolesc Psychiatry source
Not checked in the free run.
- cites [4] Dawson, 2010, Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model., Pediatrics source
Not checked in the free run.
- cites [5] D’Elia, 2014, A longitudinal study of the teacch program in different settings: the potential benefits of low intensity intervention in preschool children with autism spectrum disorder., J Autism Dev Disord source
Not checked in the free run.
- cites [6] Anderson, 2014, Predicting young adult outcome among more and less cognitively able individuals with autism spectrum disorders., J Child Psychol Psychiatry source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataCensus-tract information to link to median household income was available for 94% of children aged 4 years.
“Census-tract information to link to MHI was available for 94% of children aged 4 years; others met residency requirements on the basis of school attendance or receipt of services that required living in the surveillance area during 2018.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIncreasing the proportion of all children who receive a developmental screening by age 36 months and the proportion of children with ASD who receive special services by age 48 months are included as Healthy People 2030 goals.
“Because of the potential to improve outcomes, increasing the proportion of all children who receive a developmental screening by age 36 months and the proportion of children with ASD who receive special services by age 48 months are included as Healthy People 2030 goals (7).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2030 ASD goals. https://health.gov/healthypeople/custom-list?ids=31387+31386
Not checked in the free run.
May combine two claims.
PremisecitationSurveillance among children aged 4 years in 2016 indicated similar ASD prevalence among children of different racial and ethnic groups, consistent with trends among children aged 8 years.
“Surveillance among children aged 4 years in 2016 (8) indicated similar prevalence among children of different racial and ethnic groups, consistent with trends among children aged 8 years (9).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [8] Shaw, 2020, Early identification of autism spectrum disorder among children aged 4 years—Early Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
- cites [9] Maenner, 2020, Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll sites had access to health records, and nine of 11 sites had access to education records covering their surveillance area (Wisconsin had partial access, and Missouri had none).
“All sites had access to health records, and nine of 11 sites had access to education records covering their surveillance area (Wisconsin had partial access, and Missouri had none).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.
Interpretationnone givenImproving early identification of ASD could lead to earlier receipt of evidence-based interventions and potentially improve developmental outcomes.
“Improving early identification of ASD could lead to earlier receipt of evidence-based interventions and potentially improve developmental outcomes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll ADDM Network sites functioned as public health authorities under the Health Insurance Portability and Accountability Act of 1996 Privacy Rule and met applicable local institutional review board, privacy, and confidentiality requirements under 45 CFR 46.
“All sites functioned as public health authorities under the Health Insurance Portability and Accountability Act of 1996 Privacy Rule and met applicable local institutional review board, privacy, and confidentiality requirements under 45 CFR 46.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationEarly routine screening for ASD and other developmental concerns is recommended by the American Academy of Pediatrics.
“Early routine screening for ASD and other developmental concerns is recommended by the American Academy of Pediatrics (1) because early evaluation, diagnosis, and evidence-based interventions could enhance short-term and long-term developmental outcomes for young children with ASD (2–6).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1] Hyman, 2020, Identification, evaluation, and management of children with autism spectrum disorder., Pediatrics source
Not checked in the free run.
May combine two claims.
Interpretationown dataChildren aged 4 years had a higher cumulative incidence of diagnosis or eligibility by age 48 months compared with children aged 8 years, indicating improvement in early identification of ASD.
“Children aged 4 years had a higher cumulative incidence of diagnosis or eligibility by age 48 months compared with children aged 8 years, indicating improvement in early identification of ASD.”
- Also stated in: § Public Health Action · hedged
“Children born in 2014 were more likely to be identified with ASD by age 48 months than children born in 2010, indicating increased early identification.”
Quote in the paperSubstantial claim- Also stated in: § Public Health Action · hedged
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataNo children aged 4 years were lacking sex information; 245 children were of other (including multiracial) or unknown race and were excluded from analyses stratified by race and ethnicity.
“No children aged 4 years were lacking sex information; 245 children were of other (including multiracial) or unknown race and were excluded from analyses stratified by race and ethnicity.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationASD identification measured by cumulative incidence of diagnosis by age 48 months was higher among children aged 4 years (born in 2012) compared with children aged 8 years (born in 2008), suggesting increased early identification of ASD among the younger cohort.
“In addition, ASD identification measured by cumulative incidence of diagnosis by age 48 months was higher among children aged 4 years (born in 2012) compared with children aged 8 years (born in 2008), suggesting increased early identification of ASD among the younger cohort (8).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Shaw, 2020, Early identification of autism spectrum disorder among children aged 4 years—Early Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2016., MMWR Surveill Summ source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenSurveillance area populations are subsets of state populations and not necessarily generalizable to the entire state or United States.
“First, surveillance area populations are subsets of state populations and not necessarily generalizable to the entire state or United States.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductcitationComparisons with previous reports among children aged 4 years were limited by small numbers among non-White groups in surveillance year 2010 and a lack of aggregate estimates for surveillance years 2012 and 2014.
“Comparisons with previous reports among children aged 4 years were limited by small numbers among non-White groups in surveillance year 2010 and a lack of aggregate estimates for surveillance years 2012 and 2014 (13).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Christensen, 2019, Prevalence and characteristics of autism spectrum disorder among children aged 4 years—Early Autism and Developmental Disabilities Monitoring Network, seven sites, United States, 2010, 2012, and 2014., MMWR Surveill Summ source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe surveillance case definition of intellectual disability is not the same as a clinical diagnosis of intellectual disability.
“Finally, the surveillance case definition of intellectual disability is not the same as a clinical diagnosis of intellectual disability; IQ measurements might lack stability and children might not receive a diagnosis of intellectual disability at younger ages.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAn association of higher ASD prevalence and higher SES has been reported previously in ADDM Network data from surveillance years 2002-2010.
“An association of higher ASD prevalence and higher SES has been reported previously in ADDM Network data from surveillance years 2002–2010 (19).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Durkin, 2017, Autism spectrum disorder among US children (2002–2010): socioeconomic, racial, and ethnic disparities., Am J Public Health source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenSample size, demographics, and practices and policies vary among sites and could contribute to variability in findings.
“Second, sample size, demographics, and practices and policies vary among sites and could contribute to variability in findings.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenDifferences in sites or study areas complicate comparisons over time.
“Third, differences in sites or study areas complicate comparisons over time.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningAssessing ASD identification among children aged 4 years and children aged 8 years in a single area in a single year addresses the limitation of differences in sites or study areas by making these groups directly comparable.
“One way this limitation has been addressed is by assessing ASD identification among children aged 4 years and children aged 8 years in a single area in a single year so that these groups are directly comparable.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductreasoningData completeness varied across sites, which could result in incomplete or biased ascertainment of ASD or other characteristics such as intellectual disability.
“Fourth, data completeness varied across sites (either because of lack of data sharing agreements, pandemic-related disruption, or incomplete information), which could result in incomplete or biased ascertainment of ASD or other characteristics such as intellectual disability.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThe population of AI/AN children was small relative to other groups and thus could not be further stratified for comparisons.
“The population of AI/AN children was small relative to other groups and thus could not be further stratified for comparisons.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe "Get SET Early" program has trained hundreds of pediatricians to developmentally screen children at well-baby examinations and refer them for evaluation when indicated.
“For example, the “Get SET Early” program has trained hundreds of pediatricians to developmentally screen children at well-baby examinations and refer them for evaluation when indicated (16).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Pierce, 2021, Get SET Early to identify and treatment refer autism spectrum disorder at 1 year and discover factors that influence early diagnosis., J Pediatr source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOne of the California site's data sources was a state-funded regional center that serves persons with developmental disabilities and their families, including providing evaluations and service coordination.
“One of the site’s data sources was a state-funded regional center that serves persons with developmental disabilities and their families, including providing evaluations and service coordination (15).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] California Department of Developmental Services [Internet]. Sacramento, CA: California Department of Developmental Services; 2020. https://www.dds.ca.gov/
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningIQ measurements might lack stability and children might not receive a diagnosis of intellectual disability at younger ages.
“Finally, the surveillance case definition of intellectual disability is not the same as a clinical diagnosis of intellectual disability; IQ measurements might lack stability and children might not receive a diagnosis of intellectual disability at younger ages.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Non-White and lower median household income groups have historically had lower ASD prevalence.
“Groups with historically lower prevalence of ASD (non-White and lower MHI) had higher prevalence and cumulative incidence of ASD among children aged 4 years in 2018, suggesting progress in identification among these groups.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Although prevalence has been lower among children aged 4 years than aged 8 years in each reporting year, comparing cumulative incidence of identification by age 48 months has consistently indicated higher rates of ASD identification in younger cohorts.
“Although prevalence has been lower among children aged 4 years than aged 8 years in each reporting year, comparing cumulative incidence of identification by age 48 months has consistently indicated higher rates of ASD identification in younger cohorts (i.e., children born more recently) (9–11).”
California has had the highest prevalence among children aged 4 years and 8 years since joining the ADDM Network in 2018.
“California has had the highest prevalence among children aged 4 years and 8 years since joining the ADDM Network in 2018 (6,10,11,13)”
Surveillance in 2020 was conducted using the same methods as in 2018.
“Surveillance was conducted using the same methods as in 2018 (7,10).”
In 2020, ASD prevalence among children aged 4 years was 24.3% higher among boys and 34.5% higher among girls than prevalence in 2018.
“Prevalence in 2020 among children aged 4 years was 24.3% higher among boys and 34.5% higher among girls than prevalence in 2018 (7), but the male-to-female ratios were similar between years.”
Prevalence of suspected ASD increased from 2018 at five sites (Arizona, Arkansas, Maryland, New Jersey, and Utah) and was similar between years at other sites.
“Prevalence of suspected ASD increased from 2018 at five sites (Arizona, Arkansas, Maryland, New Jersey, and Utah) and was similar between years at other sites (7)”
ASD is beginning to be identified more in lower-SES groups than previously; however, barriers to services still exist for lower-SES families of children with ASD (e.g., transportation, childcare, and job accommodations).
“ASD is beginning to be identified more in lower-SES groups than previously (7,11); however, barriers to services still exist for lower-SES families of children with ASD (e.g., transportation, childcare, and job accommodations) (18–26).”
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078 · see citing works
Self-citationMaenner, M. J., Shaw, K. A., Baio, J., EdS1, Washington, A., Patrick, M., DiRienzo, M., Christensen, D. L., Wiggins, L. D., Pettygrove, S., et al. (2020) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6904a1 · Cited by 3,780 · cited 5× · see citing works
“In surveillance year 2018, ASD prevalence among Black children was higher than among White children at five of 11 sites and overall, the opposite of the pattern before surveillance year 2016 among children aged 8 years (9,17).”
BackgroundResultInfluentialSelf-citationDawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., Donaldson, A., & Varley, J. (2010) · Pediatrics · doi:10.1542/peds.2009-0958 · Cited by 2,621 · see citing works
Maenner, M. J., Shaw, K. A., Bakian, A. V., Bilder, D. A., Durkin, M. S., Esler, A., Furnier, S. M., Hallas, L., Hall-Lande, J., Hudson, A., et al. (2021) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7011a1 · Cited by 1,818 · cited 23× · see citing works
“Comparisons were made with the group of children aged 8 years for the same 11 sites (11).”
BackgroundMethodResultInfluentialSelf-citationIdentification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,548 · see citing works
Rogers, S. J., Estes, A., Lord, C., Vismara, L., Winter, J., Fitzpatrick, A., Guo, M., & Dawson, G. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.08.003 · Cited by 713 · see citing works
Reichow, B., Barton, E. E., Boyd, B. A., & Hume, K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009260.pub2 · Cited by 577 · see citing works
Anderson, D. K., Liang, J. W., & Lord, C. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12178 · Cited by 401 · see citing works
Reichow, B., Hume, K., Barton, E. E., & Boyd, B. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009260.pub3 · Cited by 350 · see citing works
Durkin, M. S., Maenner, M. J., Baio, J., Christensen, D., Daniels, J., Fitzgerald, R., Imm, P., Lee, L.-C., Schieve, L. A., Van Naarden Braun, K., et al. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.304032 · Cited by 347 · see citing works
Self-citationChristensen, D. L., Maenner, M. J., Bilder, D., Constantino, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., Pettygrove, S. D., Robinson, C., et al. (2019) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6802a1 · Cited by 344 · see citing works
Self-citationShaw, K. A., Maenner, M. J., Baio, J., EdS1, Washington, A., Christensen, D. L., Wiggins, L. D., Pettygrove, S., Andrews, J. G., White, T., et al. (2020) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6903a1 · Cited by 286 · see citing works
Self-citationRoman-Urrestarazu, A., van Kessel, R., Allison, C., Matthews, F. E., Brayne, C., & Baron-Cohen, S. (2021) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2021.0054 · Cited by 242 · see citing works
Socioeconomic Disparities and Prevalence of Autism Spectrum Disorders and Intellectual Disability
Delobel-Ayoub, M., Ehlinger, V., Klapouszczak, D., Maffre, T., Raynaud, J.-P., Delpierre, C., & Arnaud, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0141964 · Cited by 210 · see citing works
D’Elia, L., Valeri, G., Sonnino, F., Fontana, I., Mammone, A., & Vicari, S. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1911-y · Cited by 70 · see citing works
Patrick, M. E., Shaw, K. A., Dietz, P. M., Baio, J., Yeargin-Allsopp, M., Bilder, D. A., Kirby, R. S., Hall-Lande, J. A., Harrington, R. A., Lee, L.-C., et al. (2021) · Disability and Health Journal · doi:10.1016/j.dhjo.2020.101023 · Cited by 70 · see citing works
Self-citationShaw, K. A., McArthur, D., Hughes, M. M., Bakian, A. V., Lee, L., Pettygrove, S. D., & Maenner, M. J. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2021.11.019 · Cited by 68 · see citing works
Self-citationPierce, K., Gazestani, V., Bacon, E., Courchesne, E., Cheng, A., Barnes, C. C., Nalabolu, S., Cha, D., Arias, S., Lopez, L., et al. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.04.041 · Cited by 66 · cited 1× · see citing works
“For example, the “Get SET Early” program has trained hundreds of pediatricians to developmentally screen children at wellbaby examinations and refer them for evaluation when indicated (16).”
BackgroundSelf-citationImm, P., White, T., & Durkin, M. S. (2019) · Autism · doi:10.1177/1362361319827510 · Cited by 35 · see citing works
Self-citationThe social patterning of autism diagnoses reversed in California between 1992 and 2018.
Winter, A. S., Fountain, C., Cheslack-Postava, K., & Bearman, P. S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015762117 · Cited by 33 · see citing works
Maenner, M. J., Graves, S. J., Peacock, G., Honein, M. A., Boyle, C. A., & Dietz, P. M. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwab106 · Cited by 18 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Maenner, M. J., Warren, Z., Williams, A. R., Amoakohene, E., Bakian, A. V., Bilder, D. A., Durkin, M. S., Fitzgerald, R. T., Furnier, S. M., Hughes, M. M., et al. (2023) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7202a1 · Cited by 2,706 · see citing works
Self-citationMaenner, M. J., Shaw, K. A., Bakian, A. V., Bilder, D. A., Durkin, M. S., Esler, A., Furnier, S. M., Hallas, L., Hall-Lande, J., Hudson, A., et al. (2021) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7011a1 · Cited by 1,818 · see citing works
Self-citationShaw, K. A., Williams, S., Patrick, M. E., Valencia-Prado, M., Durkin, M. S., Howerton, E. M., Ladd-Acosta, C. M., Pas, E. T., Bakian, A. V., Bartholomew, P., et al. (2025) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7402a1 · Cited by 867 · see citing works
Self-citationFu, J. M., Satterstrom, F. K., Peng, M., Brand, H., Collins, R. L., Dong, S., Wamsley, B., Klei, L., Wang, L., Hao, S. P., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01104-0 · Cited by 640 · see citing works
The global prevalence of autism spectrum disorder: A three-level meta-analysis
Talantseva, O. I., Romanova, R. S., Shurdova, E. M., Dolgorukova, T. A., Sologub, P. S., Titova, O. S., Kleeva, D. F., & Grigorenko, E. L. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1071181 · Cited by 318 · see citing works
Neuroinflammation and Oxidative Stress in the Pathogenesis of Autism Spectrum Disorder
Usui, N., Kobayashi, H., & Shimada, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065487 · Cited by 267 · see citing works
Shaw, K. A., Bilder, D. A., McArthur, D., Williams, A. R., Amoakohene, E., Bakian, A. V., Durkin, M. S., Fitzgerald, R. T., Furnier, S. M., Hughes, M. M., et al. (2023) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7201a1 · Cited by 223 · see citing works
Self-citationAutism Diagnosis Among US Children and Adults, 2011-2022
Grosvenor, L. P., Croen, L., Lynch, F. L., Marafino, B. J., Maye, M. P., Penfold, R. B., Simon, G. E., & Ames, J. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.42218 · Cited by 143 · see citing works
Megerian, J. T., Dey, S., Melmed, R. D., Coury, D. L., Lerner, M., Nicholls, C. J., Sohl, K., Rouhbakhsh, R., Narasimhan, A., Romain, J. E., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00598-6 · Cited by 114 · see citing works
Zhao, J., Zhang, X., Lu, Y., Wu, X., Fujun, Z., Yang, S., Wang, L., Wu, X., & Fei, F. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1029392 · Cited by 102 · see citing works
Hung, L. Y., & Margolis, K. G. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00857-1 · Cited by 96 · see citing works
Xu, X., Sun, B., & Zhao, C. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106314 · Cited by 70 · see citing works
Pham, A. V., & Charles, L. C. (2023) · Current Psychiatry Reports · doi:10.1007/s11920-023-01417-9 · Cited by 64 · see citing works
Burrows, C. A., Grzadzinski, R., Donovan, K., Stallworthy, I. C., Rutsohn, J., John, T. S., Marrus, N. M., Parish‐Morris, J., MacIntyre, L., Hampton, J., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.05.027 · Cited by 57 · see citing works
Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder
Chang, X., Zhang, Y., Chen, X., Li, S., Mei, H., Xiao, H., Ma, X., Liu, Z., & Li, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-54717-2 · Cited by 41 · see citing works
Quality of life in parents of autistic children: A transcultural perspective
Eapen, V., Karlov, L., John, J. R., Beneytez, C., Grimes, P. Z., Kang, Y. Q., Mardare, I., Mincă, D. G., Voicu, L., Malek, K. A., et al. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1022094 · Cited by 34 · see citing works
Gan, H., Su, Y., Zhang, L., Huang, G., Lai, C., Lv, Y. H., & Li, Y. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1120728 · Cited by 43 · see citing works
Singla, R., Mishra, A., & Cao, R. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02120-8 · Cited by 33 · see citing works
Su, W.-C., Culotta, M. L., Tsuzuki, D., & Bhat, A. N. (2022) · Scientific Reports · doi:10.1038/s41598-022-08689-w · Cited by 32 · see citing works
Otero, A. M., Connolly, M. G., Gonzalez-Ricon, R., Wang, S. S., Allen, J. M., & Antonson, A. M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02648-9 · Cited by 31 · see citing works
Prevalence of autism spectrum disorder in a large pediatric primary care network
Wallis, K. E., Adebajo, T., Bennett, A. E., Drye, M., Gerdes, M., Miller, J. S., & Guthrie, W. (2023) · Autism · doi:10.1177/13623613221147396 · Cited by 30 · see citing works
Bjørklund, G., Mkhitaryan, M., Sahakyan, E., Fereshetyan, K., Meguid, N. A., Hemimi, M., Nashaat, N. H., & Yenkoyan, K. B. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03941-y · Cited by 27 · see citing works
Megari, K., Frantzezou, C. K., Polyzopoulou, Z. A., & Tzouni, S. K. (2024) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10356 · Cited by 27 · see citing works
Yuan, B., Wang, M., Wu, X., Cheng, P., Zhang, R., Zhang, R., Yu, S., Zhang, J., Du, Y., Wang, X., et al. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01037-6 · Cited by 26 · see citing works
Bidirectional genetic overlap between autism spectrum disorder and cognitive traits
Hope, S., Shadrin, A. A., Lin, A., Bahrami, S., Rødevand, L. N., Frei, O., Hübenette, S. J., Cheng, W., Hindley, G., Nag, H. E., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02563-7 · Cited by 25 · see citing works
da Silva, A. C. F., Barbosa, T. D. S., & Gavião, M. B. D. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021151 · Cited by 25 · see citing works
Metabolomic analysis of maternal mid-gestation plasma and cord blood in autism spectrum disorders
Che, X., Roy, A., Bresnahan, M. A., Mjaaland, S., Reichborn‐Kjennerud, T., Magnus, P. M., Stoltenberg, C., Shang, Y., Zhang, K., Susser, E., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02051-w · Cited by 25 · see citing works
Alteration of peripheral cortisol and autism spectrum disorder: A meta-analysis
Gao, J., Zou, J., Yang, L., Zhao, J., Wang, L. Y., Liu, T., & Fan, X. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.928188 · Cited by 23 · see citing works
Mahmood, M. A., Jamel, L., Alturki, N. M., & Tawfeek, M. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-96014-6 · Cited by 22 · see citing works
RetractedSalgado, N. D. M., Pantoja, J. C., Viana, R. P. F., & Pereira, R. G. V. (2022) · Research Society and Development · doi:10.33448/rsd-v11i13.35748 · Cited by 71 · see citing works
Why do we need sex‐balanced studies of autism?
Nordahl, C. W. (2023) · Autism Research · doi:10.1002/aur.2971 · Cited by 20 · see citing works
Hughes, M. M., Shaw, K. A., Patrick, M., DiRienzo, M., Bakian, A. V., Bilder, D. A., Durkin, M. S., Hudson, A., Spivey, M. H., DaWalt, L. S., et al. (2023) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2022.12.010 · Cited by 20 · see citing works
Self-citationKlaiman, C., White, S. P., Richardson, S. S., McQueen, E., Walum, H., Aoki, C., Smith, C. J., Minjarez, M., Bernier, R., Pedapati, E. V., et al. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05812-8 · Cited by 19 · see citing works
Waite, D., & Burd, L. (2023) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2023.10877 · Cited by 18 · see citing works
Consanguinity as a Risk Factor for Autism
Alshaban, F. A. W., Aldosari, M., Ghazal, I., Al‐Shammari, H., Elhag, S. F., Thompson, I. R., Bruder, J., Shaath, H., Al‐Faraj, F., Tolefat, M., et al. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06137-w · Cited by 18 · see citing works
Pediatric Bipolar Disorder: Challenges in Diagnosis and Treatment
Wozniak, J. R., O’Connor, H., Iorini, M., & Ambrose, A. J. H. (2024) · Pediatric Drugs · doi:10.1007/s40272-024-00669-z · Cited by 22 · see citing works
Is tuberous sclerosis complex-associated autism a preventable and treatable disorder?
Curatolo, P., Scheper, M., Gialloreti, L. E., Specchio, N., & Aronica, E. (2023) · World Journal of Pediatrics · doi:10.1007/s12519-023-00762-2 · Cited by 17 · see citing works
Taddei, M., Bulgheroni, S., Toffalini, E., Pantaleoni, C., & Lanfranchi, S. (2023) · Autism Research · doi:10.1002/aur.2953 · Cited by 17 · see citing works
García-Zambrano, S., Orozco-Barrios, L. G., & Jacobs, E. (2022) · Research in Autism · doi:10.1016/j.rasd.2022.102045 · Cited by 15 · see citing works
Autism spectrum disorder in the fragile X premutation state: possible mechanisms and implications
Aishworiya, R., Protic, D. D., & Hagerman, R. J. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11209-5 · Cited by 15 · see citing works
Chen, W., Liu, X., Huang, Z., Guo, C., Feng, F., Zhang, Y., Gao, Y., Zheng, K., Huang, J., Yu, J., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1211684 · Cited by 14 · see citing works
Eldeeb, S. Y., Ludwig, N. N., Wieckowski, A. T., Dieckhaus, M. F. S., Algur, Y., Ryan, V., Dufek, S., Stahmer, A. C., & Robins, D. L. (2023) · Autism · doi:10.1177/13623613231154728 · Cited by 15 · see citing works
Li, Q., Shi, Y., Li, X. O., Yang, Y., Zhang, X., Xu, L., Ma, Z., Lu, T., Xu, R., Fan, L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315290 · Cited by 13 · see citing works
Din, Q. M. U., & Jayanthy, A. K. (2022) · Biomedical Engineering Applications Basis and Communications · doi:10.4015/s1016237222500466 · Cited by 13 · see citing works
Prevalence of Autism Spectrum Disorder in the United States is Stable in the COVID-19 Era
Wang, X., Weng, X., Pan, N., Li, X., Lin, L., & Jin, J. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-05915-w · Cited by 13 · see citing works
Genomic Strategies for Understanding the Pathophysiology of Autism Spectrum Disorder
Doi, M., Li, M., Usui, N., & Shimada, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.930941 · Cited by 12 · see citing works
MicroRNA and MicroRNA-Target Variants Associated with Autism Spectrum Disorder and Related Disorders
Wong, A. D., Zhou, A., Cao, X., Mahaganapathy, V., Azaro, M. A., Gwin, C., Wilson, S., Buyske, S. G., Bartlett, C. W., Flax, J. F., et al. (2022) · Genes · doi:10.3390/genes13081329 · Cited by 14 · see citing works
Moro, J. D. S., Rodrigues, T. D., Kammer, P. V., de Camargo, A. R., & Bolan, M. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05820-8 · Cited by 12 · see citing works
Autistic Women’s Experiences of the Perinatal Period: A Systematic Mixed Methods Review
Westgate, V., Sewell, O., Caramaschi, D., & O’Mahen, H. (2024) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-024-00461-2 · Cited by 13 · see citing works
Sesay, M. M., McCracken, C., Stewart, C. C., Simon, G. E., Penfold, R. B., Ahmedani, B. K., Rossom, R. C., Lu, C. Y., Beck, A. L., Coleman, K. J., et al. (2024) · Autism · doi:10.1177/13623613231220687 · Cited by 11 · see citing works
Patti, M. A., Croen, L., Dickerson, A. S., Joseph, R. M., Ames, J., Ladd‐Acosta, C., Ozonoff, S. J., Schmidt, R. J., Volk, H. E., Hipwell, A. E., et al. (2024) · Autism Research · doi:10.1002/aur.3147 · Cited by 11 · see citing works
Self-citationLanguage Skill Differences Further Distinguish Social Sub-types in Children with Autism
Zhao, W., Li, Q., Zhang, X., Song, X., Zhu, S., Shou, X., Meng, F., Xu, X., Zhang, R., & Kendrick, K. M. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05759-w · Cited by 11 · see citing works
He, C., Zhou, H., Chen, L., & Liu, Z. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04309-y · Cited by 10 · see citing works
Pettinato, F., Valle, M. S., Cioni, M., Cirnigliaro, L., Rizzo, R., Barone, R., Bosco, G., & Casabona, A. (2024) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-024-01520-9 · Cited by 9 · see citing works
Xie, K., Sun, Y., Li, X., Yang, S., Wang, M., Zhang, Y., Wang, Q., Wu, K., Kong, D., Guo, T., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01922-9 · Cited by 9 · see citing works
Hu, C., Wang, Y., Li, C., Mei, L., Zhou, B., Li, D., Li, H., Xu, Q., & Xu, X. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1083779 · Cited by 9 · see citing works
Hao, X., Ma, M., Tao, J., Cao, J., Qin, J., Liu, F., Zhang, D., & Ming, D. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3544302 · Cited by 8 · see citing works
Wang, Y., Zhijia, L., Ye, Y., Li, Y., Wei, R., Gan, K., Qian, Y., Xu, L., Kong, Y., Guan, L., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-93631-z · Cited by 8 · see citing works
Smythe, L., Asan, L., Nicholson, T. R., Happe, F. G. E., & Edwards, M. J. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13385-6 · Cited by 8 · see citing works
Purushotham, S. S., Reddy, N. M. N., D’Souza, M. N., Choudhury, N. R., Ganguly, A., Gopalakrishna, N., Muddashetty, R. S., & Clement, J. P. (2022) · Experimental Brain Research · doi:10.1007/s00221-022-06448-x · Cited by 8 · see citing works
Statewide county-level autism spectrum disorder prevalence estimates—seven U.S. states, 2018
Shaw, K. A., Williams, S., Hughes, M. M., Warren, Z. E., Bakian, A. V., Durkin, M. S., Esler, A., Hall‐Lande, J., Salinas, A., Vehorn, A. C., et al. (2023) · Annals of Epidemiology · doi:10.1016/j.annepidem.2023.01.010 · Cited by 8 · see citing works
Self-citationScreening Success in the Age of Autism
Lipkin, P. H. (2023) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2022.5972 · Cited by 8 · see citing works
SSMDA: Semi-supervised multi-source domain adaptive autism prediction model using neuroimaging
Mengi, M., & Malhotra, D. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.106337 · Cited by 7 · see citing works
Patrick, M., Williams, A. R., Shaw, K. A., Durkin, M. S., Hall‐Lande, J., Vehorn, A. C., & Hughes, M. M. (2025) · Annals of Epidemiology · doi:10.1016/j.annepidem.2025.02.014 · Cited by 7 · see citing works
Self-citationHuang, Z., Wei, A., Yuan, H., Huang, S., Chen, X., Han, Y., & Li, X. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05922-z · Cited by 7 · see citing works
Stankovic, I., Smit, P., Cross, J., Rai, A., Wolujewicz, P., Greening, D. W., & Colak, D. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03607-w · Cited by 7 · see citing works
Moody, C. T., Schiltz, H. K., Ratto, A. B., Gulsrud, A. C., & Laugeson, E. A. (2022) · International review of research in developmental disabilities · doi:10.1016/bs.irrdd.2022.05.007 · Cited by 7 · see citing works
Assessment Tools for Autism Spectrum Disorder (ASD) Developed in India: A Scoping Review
Sreelakshmi, A. C. A., Patil, R., Veena, K. D., Aroor, S., Rajashekhar, B., & Dhyani, V. S. (2025) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-025-00495-0 · Cited by 9 · see citing works
Kim, A. J. H., Zisman, C. R., & Holingue, C. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_371 · Cited by 7 · see citing works
Zheng, R., Huang, S., Feng, P., Liu, S., Jiang, M., Li, H., Zheng, P., Mi, Y., & Li, E. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1557174 · Cited by 6 · see citing works
Lopez, K. (2024) · Healthcare · doi:10.3390/healthcare12232381 · Cited by 7 · see citing works
Mohamed, F. R. R., Irfan, M., Raja, A., Sattar, M. A., Matairi, A. A., Firdous, R. M., Sharma, A., Alghanem, J., Kalou, A., Abdalgader, Y. H. H., et al. (2025) · Research in Autism · doi:10.1016/j.reia.2025.202579 · Cited by 5 · see citing works
Access to services for autistic people across Europe
Ikhsan, S. N. B. M., Holt, R., Man, J., Parsons, T. A., Schalbroeck, R., Ruigrok, A. N. V., Baranger, A., Allison, C. L., Doherty, M., den Bosch, K. V., et al. (2025) · Molecular Autism · doi:10.1186/s13229-025-00664-2 · Cited by 5 · see citing works
Lu, Y., Zhang, L., Wu, X., Fei, F.-R., & Han, H. (2022) · Disease Markers · doi:10.1155/2022/3372217 · Cited by 5 · see citing works
Xiao, Q., Xu, H., Chu, Z., Feng, Q., & Zhang, Y. (2023) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2023.3294223 · Cited by 5 · see citing works
Chihuri, S., Blanchard, A., DiGuiseppi, C. G., & Li, G. (2024) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06091-7 · Cited by 5 · see citing works
Richards, J. E., Guy, M. W., Hogan, A. L., & Roberts, J. E. (2023) · Autism Research · doi:10.1002/aur.3045 · Cited by 5 · see citing works
Burkett, K., Brown, C. L., Pickler, R. H., Stanton‐Chapman, T. L., Sharps, P. W., Jacquez, F., Smith, T. C., Holland, A., Heeman, A., & Froehlich, T. E. (2024) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000001327 · Cited by 5 · see citing works
Guo, D., Yang, X., Gao, M., Chen, X., Tang, Y., Shen, L., Li, K., & Shi, L. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01233-4 · Cited by 5 · see citing works
PASS neurocognitive assessment of children with autism spectrum disorder
Otero, T. M., & Naglieri, J. A. (2022) · Psychology in the Schools · doi:10.1002/pits.22798 · Cited by 5 · see citing works
Morrier, M. J., Schwartz, A. J., Rice, C. E., Platner, A. K., Ousley, O., Kassem, S., Krishnan, A. V., Lord, C., Smith, C. J., & Oberleitner, R. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06116-1 · Cited by 5 · see citing works
Russell, L., Tinker, S. C., Shaw, K. A., Maenner, M. J., DiRienzo, M., Kirby, A. V., Howerton, E. M., Vanegas, S. B., & Lopez, M. L. C. (2026) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-026-07292-6 · Cited by 4 · see citing works
Self-citationPredictive Analysis of Parent Activation and Autism
McGrew, J. H., Yu, Y., Ruble, L. A., & Murray, D. S. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-05985-w · Cited by 6 · see citing works
Criss, S. D., Kakulamarri, S., Xu, R. F., Fajardo, M., Keeney, T., Tolchin, D. W., & May, C. J. (2023) · Children · doi:10.3390/children10050906 · Cited by 4 · see citing works
Kazantzidou, P., Αντωνοπούλου, Κ., Costarelli, V., & Papanikolaou, G. (2023) · International Journal of Developmental Disabilities · doi:10.1080/20473869.2023.2215012 · Cited by 4 · see citing works
Taheri, F., Joushi, S., Mohammadipoor‐Ghasemabad, L., Rad, I., Esmaeilpour, K., & Sheibani, V. (2024) · Birth Defects Research · doi:10.1002/bdr2.2300 · Cited by 4 · see citing works
Specific Phobia, Fear, and the Autism Spectrum in Children and Adolescents: Adapting OST for ASD
Davis, T. E., & Brennan, J. (2024) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-024-00475-6 · Cited by 4 · see citing works
Wieckowski, A. T., Liz, G. P., de Marchena, A. B., FEIN, D. A., Barton, M. L., Vivanti, G., & Robins, D. L. (2024) · Autism · doi:10.1177/13623613241252312 · Cited by 4 · see citing works
Wei, F., Chen, T., Huang, Y., Yang, Y., Cheng, X., & Yang, L. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02243-1 · Cited by 4 · see citing works
Tooth brushing behavior and oral health care of people with early childhood autism in Germany
Kraus, H., Schulte, A. G., Fricke, O., & Schmidt, P. (2025) · Clinical Oral Investigations · doi:10.1007/s00784-025-06194-8 · Cited by 4 · see citing works
Grammatical comprehension in language and communication disorders
Garrido, D., López, J. M., Fresneda, D., Mendoza, E., García‐Retamero, R., & Carballo, G. (2023) · Clinical Linguistics & Phonetics · doi:10.1080/02699206.2023.2237647 · Cited by 3 · see citing works
Altered monocyte subpopulations and their association with autism spectrum disorder risk in children
Li, W., Zhang, L., Xu, Y., Li, H., Li, B., Sun, S., Zhang, X., Duan, G., Chen, Y., Zhang, J., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.02.028 · Cited by 3 · see citing works
Madhavilatha, I., & Krishna, K. H. (2025) · International Conference on Intelligent and Innovative Technologies in Computing, Electrical and Electronics (IITCEE) · doi:10.1109/iitcee64140.2025.10915458 · Cited by 3 · see citing works
Rea, C. J., Lesch, K., Hernández, B., Sprecher, E., Hauptman, M., Epee-Bounya, A., Wilson, K., & Shah, S. N. (2025) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000001399 · Cited by 3 · see citing works
Zhang, J., Han, Y., Li, W., Zhang, Q., Chen, D., & Bao, C. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120453 · Cited by 3 · see citing works
A deep learning model for diagnosing autism using brain time series
Wang, X., Pei, C., He, J., & Xu, J. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.001 · Cited by 3 · see citing works
Feng, J., Bai, M.-S., Dong, H.-Y., Yang, X., Liu, Y.-M., Ma, H., Mohamed, Z. A., Shan, L., & Jia, F. (2025) · Pediatric Research · doi:10.1038/s41390-025-04375-5 · Cited by 3 · see citing works
Longitudinal multi-omics analysis of umbilical cord blood and childhood serum in Autism
Noone, A., Dowling, K. G., O’Boyle, D., Carter, M., Golubeva, A. V., Scaife, C., Bech, B. H., Henriksen, T. B., Gallagher, L., Mooney, C., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03157-z · Cited by 3 · see citing works
Familiarity of evidence based practices in Chinese caregivers of autistic children
Bak, M. Y. S., Reilly, A. M., Yang, Y., Abas, H., Pan, Q., & Hugh, M. L. (2022) · International Journal of Developmental Disabilities · doi:10.1080/20473869.2022.2142374 · Cited by 3 · see citing works
Quinn, M., & Porter, S. (2023) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2023.104578 · Cited by 3 · see citing works
- Authors
- Shaw, K. A., Maenner, M. J., Bakian, A. V., Bilder, D. A., Durkin, M. S., Furnier, S. M., Hughes, M. M., Patrick, M., Pierce, K., Salinas, A., Shenouda, J., Vehorn, A., Warren, Z., Zahorodny, W., Constantino, J. N., DiRienzo, M., Esler, A., Fitzgerald, R. T., Grzybowski, A., Hudson, A., Spivey, M. H., Ali, A., Andrews, J. G., Baroud, T., Gutierrez, J., Hallas, L., Hall-Lande, J., Hewitt, A., Lee, L.-C., Lopez, M., Mancilla, K. C., McArthur, D., Pettygrove, S., Poynter, J. N., Schwenk, Y. D., Washington, A., Williams, S., & Cogswell, M. E.
- Affiliations
- Centers for Disease Control and Prevention (US)
- University of Utah (US)
- University of Wisconsin–Madison (US)
- University of California San Diego (US)
- Rutgers New Jersey Medical School (US)
- Vanderbilt University Medical Center (US)
- Washington University in St. Louis (US)
- University of Minnesota (US)
- University of Arkansas for Medical Sciences (US)
- Johns Hopkins University (US)
- University of Arizona (US)
- Corresponding author
- Shaw, Kelly A.
- ORCID
- Maenner, Matthew J.
- Bakian, Amanda V.
- Bilder, Deborah A.
- Durkin, Maureen S.
- Furnier, Sarah M.
- Hughes, Michelle M.
- Patrick, Mary
- Pierce, Karen
- Shenouda, Josephine
- Warren, Zachary
- Zahorodny, Walter
- Constantino, John N.
- DiRienzo, Monica
- Esler, Amy
- Fitzgerald, Robert T.
- Ali, Akilah
- Andrews, Jennifer G.
- Lee, Li-Ching
- Lopez, Maya
- McArthur, Dedria
- Pettygrove, Sydney
- Poynter, Jenny N.
- Washington, Anita
- Cogswell, Mary E.
- Venue
- MMWR. Surveillance Summaries
- Published
- 2021-12-03
- Volume
- 70
- Issue
- 10
- Pages
- 1-14
- ISSN
- 1545-8636 (ISSN-L)
- 1546-0738
- PMC
- PMC8639027
- OpenAlex
- W3216090687
- Semantic Scholar
- df608850c56451ca698c05b395e62b4fce952bd2
- Cited by
- 165
- References
- 22
- Citations by year
- 2026: 7 · 2025: 50 · 2024: 31 · 2023: 48 · 2022: 28 · 2021: 1
- FWCI
- 14.20
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Surveillance Summaries (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD103537)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Social Sciences › Psychology › Clinical Psychology › Family and Disability Support Research
- Keywords
- autism spectrum disorder, autism prevalence, early detection, racial and ethnic disparities, sex differences, household income, special education eligibility, intellectual disability
- MeSH terms
- Autism Spectrum Disorder, Child, Preschool, Female, Humans, Male, Population Surveillance, United States, Early Diagnosis, Epidemiological Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review